FINANCIALS

ABCL Abcellera Biologics Inc 1703057

Income Statement
Revenue	abcl-20241231	28,833,000
Net Income	abcl-20241231	-162,857,000
Profit Margin		-564.83%

Balance Sheet
Current Assets	751,370,000
Assets	1,360,553,000
Current Liabilities	76,612,000
Liabilities	304,469,000
Equity	1,056,084,000
Shares Out	294,666,000

Cash Flow Statement
Operating Cash Flow	-108,556,000
Investing Cash Flow	121,409,000

Market Analysis
Market Cap	814,750,138
Price	2.40
BVPS	3.58
PB	0.66
EPS	-0.53
PS	7.06
FCF	12,853,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view ABCL documents filed with the SEC.

ABCL Filings Clear

View A List of Tickers